ASTRO Flash Conference
October 24, 2021
Video file
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
IBA hosted during ASTRO a special Flash Conference with industry experts such as Jim Metz, Lei Dong, Costas Koumenis, and more.
- Agenda:
- Frederic Genin | Introduction
- Jim Metz | FLASH Will Define the Future of Proton Therapy
- Lei Dong | Dosimetry and QA Challenges for ConformalFLASH®
- François Vander Stappen | Technological Path Towards ConformalFLASH®
- Panel Discussion: Jim Metz, Lei Dong, Francois Vander Stappen, Jing Zeng, William Hartsell, Jan Schuemann, and Costas Koumenis
Flash Therapy is currently under research and development phase and will be available for sale when regulatory clearance is received.
Key content topics
Guest speakers
Lei
Dong
Professor, Director of Medical Physics
University of Pennsylvania - Roberts Proton Therapy Center
François
Vander Stappen
R&D Research Expert
IBA
James
Metz
Chair of Penn Medicine Roberts Proton Therapy Center
University of Pennsylvania
Related contents
Proton Therapy Publication
April 2024
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
Proton Therapy Publication
November 2023
Proton Therapy Mediates Dose Reductions to Brain Structures Associated with Cognition in Children with Medulloblastoma.
Proton Therapy Publication
October 2023
Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy.
Proton Therapy Publication
September 2023
Ultra-High Dose-Rate Proton FLASH Improves Tumor Control.
Proton Therapy Publication
June 2023
The current status of FLASH particle therapy: a systematic review.
Proton Therapy Publication
May and June 2023
ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.
Proton Therapy Publication
April 2023
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
Proton Therapy Publication
March 2023
A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Proton Therapy Publication
November 2022
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.